Skip to content

The effect of of different doses of succinylcholine and rocuronium on apnea durationin following rapid sequence induction of general anesthesia: a prospective observational study

The effect of of different doses of succinylcholine and rocuronium on apnea durationin following rapid sequence induction of general anesthesia: a prospective observational study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000034769
Enrollment
Unknown
Registered
2020-07-18
Start date
2020-07-27
Completion date
Unknown
Last updated
2020-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

general anesthesia

Interventions

1.0 mg/kg succinylcholine group, 1.5 mg/kg succinylcholine group and 1.2 mg/kg rocuronium group :Nil

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: ASA physical status I-II, aged 18-65 years, scheduled for selective surgery, sign the infomed consent.

Exclusion criteria

Exclusion criteria: 1. Pregnancy; 2. Difficult intubation history; 3. Obstructive sleep apnea syndrome; 4. Respiratory infection in recent 1 month; 5. Quit smoking less than two months before operation; 6. Have a history of alcohol or drug abuse; 7. Cerebrovascular diseases and increased intracranial pressure; 8. Administration of drugs that can attenuate rocuronium (such as phenytoin sodium, carbamazepine or protease inhibitors).

Design outcomes

Primary

MeasureTime frame
Apnea durationin;Tracheal intubation conditions;Classification of laryngoscope exposure;

Secondary

MeasureTime frame
Fibrillation time;Classification of muscle fibrillation degree;Heart rate;Blood pressure;ETO2;PETCO2;SpO2;Nasopharynx temperature;BIS;Arterial blood gas analysis;Adverse event;

Countries

China

Contacts

Public ContactLijun Tang

Department of Anesthesiology, Shanghai General Hospital

au995@139.com+86 13482602532

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026